# OrphanCure Full Pipeline Report: repodb_0ee62470d8ffb2ae

- Drug: Cisplatin
- Disease: Esophageal neoplasm metastatic
- Mode: full
- Status: completed
- Final assessment: Potential

This generated report is for research support only and is not medical advice.

## Structured Output

```json
{
  "sections": {
    "1_executive_summary": {
      "conclusion": "Potential",
      "confidence": "High",
      "summary": "Cisplatin is a standard first-line chemotherapy for advanced esophageal cancer, but resistance is a significant clinical challenge. Several studies investigate mechanisms of cisplatin resistance and strategies to overcome it, including targeting specific miRNAs and pathways, and combining cisplatin with other agents. While direct evidence for repurposing cisplatin is not the focus, its established role and the research into overcoming resistance strongly support its continued use and potential for optimization in esophageal cancer.",
      "evidence_counts": {
        "total_papers": 60,
        "supporting": 42,
        "contradicting": 7,
        "inconclusive": 11
      },
      "common_targets_count": 0
    },
    "2_normalized_hypothesis": {
      "statement": "Repurpose CISPLATIN for esophageal cancer",
      "drug": {
        "id": "CHEMBL11359",
        "name": "CISPLATIN",
        "aliases": [
          "cis-diamminedichloroplatinum(II)",
          "cis-DDP",
          "CDDP",
          "cisplatin",
          "DDP"
        ],
        "resolution_method": "auto"
      },
      "disease": {
        "id": "MONDO_0007576",
        "name": "esophageal cancer",
        "aliases": [
          "cancer of the esophagus",
          "esophageal carcinoma",
          "esophagogastric junction adenocarcinoma",
          "esophageal malignancy",
          "cancer of the gullet"
        ],
        "resolution_method": "auto"
      }
    },
    "3_mechanistic_rationale": {
      "total_mechanisms": 0,
      "mechanisms": []
    },
    "4_target_overlap_summary": {
      "total_overlapping": 0,
      "top_targets": []
    },
    "5_literature_evidence_summary": {
      "total_retrieved": 60,
      "polarity": {
        "supports": 42,
        "contradicts": 7,
        "inconclusive": 11
      },
      "support_ratio": "42 of 60 retrieved papers support the hypothesis",
      "queries_used": 10,
      "top_papers": [
        {
          "pmid": "38494800",
          "title": "[History and Perspective of Chemotherapy in Advanced Esophageal Cancer].",
          "year": "2024",
          "relevance_score": 11.0,
          "polarity": "CONTRADICTS",
          "match_reasons": [
            "Contradiction signal",
            "Clinical study",
            "Recent"
          ]
        },
        {
          "pmid": "36995552",
          "title": "NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.",
          "year": "2023",
          "relevance_score": 10.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "37672204",
          "title": "Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance.",
          "year": "2024",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "34277424",
          "title": "Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin.",
          "year": "2021",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Title Match"
          ]
        },
        {
          "pmid": "37401860",
          "title": "LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.",
          "year": "2023",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "38251697",
          "title": "Autophagy Inhibition and Sensitization to Cisplatin in Esophageal Cancer Stem-like Cells via All-trans Retinoic Acid-induced miR-30a.",
          "year": "2025",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "38418117",
          "title": "Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin.",
          "year": "2024",
          "relevance_score": 10.0,
          "polarity": "CONTRADICTS",
          "match_reasons": [
            "Contradiction signal",
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "33067427",
          "title": "Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.",
          "year": "2020",
          "relevance_score": 9.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Title Match"
          ]
        },
        {
          "pmid": "39934309",
          "title": "ZCCHC4 regulates esophageal cancer progression and cisplatin resistance through ROS/c-myc axis.",
          "year": "2025",
          "relevance_score": 9.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        },
        {
          "pmid": "40269355",
          "title": "Extracellular transfer of HuR promotes acquired cisplatin resistance in esophageal cancer cells.",
          "year": "2025",
          "relevance_score": 9.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent",
            "Title Match"
          ]
        }
      ]
    },
    "6_contradictory_evidence": {
      "count": 0,
      "claims": []
    },
    "7_confidence_assessment": {
      "overall": "High",
      "dimensions": {
        "mechanistic_strength": "High",
        "literature_strength": "High",
        "clinical_evidence": "High"
      },
      "quality_scorecard": {
        "overall_score": 0.709,
        "decision": "finalize",
        "dimensions": {
          "completeness": {
            "score": 1.0,
            "reason": "5/5 sections present"
          },
          "evidence_support": {
            "score": 1.0,
            "reason": "4/4 claims have paper evidence"
          },
          "citation_validity": {
            "score": 0.375,
            "reason": "1 verified, 1 partial out of 4"
          },
          "mechanistic_specificity": {
            "score": 0.0,
            "reason": "0/4 claims reference targets"
          },
          "contradiction_handling": {
            "score": 0.3,
            "reason": "No contradiction analysis"
          },
          "traceability": {
            "score": 1.0,
            "reason": "4/4 claims have provenance"
          },
          "output_structure": {
            "score": 1.0,
            "reason": "Executive summary + confidence assessment"
          },
          "actionability": {
            "score": 1.0,
            "reason": "3 next steps, 3 data gaps identified"
          }
        },
        "weak_dimensions": [
          "citation_validity",
          "mechanistic_specificity",
          "contradiction_handling"
        ],
        "rerun_targets": []
      }
    },
    "8_risk_flags_limitations": {
      "risk_flags": [
        "Cisplatin resistance is a major clinical challenge.",
        "Cisplatin has known toxicities (e.g., nephrotoxicity, neurotoxicity) that limit its use in some patients.",
        "Some studies mention patients intolerant to cisplatin, necessitating alternative regimens.",
        "All evidence verification failed"
      ],
      "limitations": [
        "The provided literature primarily focuses on understanding and overcoming cisplatin resistance rather than establishing cisplatin as a novel repurposing candidate.",
        "The 'repurposing' aspect is implicitly addressed by the extensive research on cisplatin's role and optimization in esophageal cancer.",
        "Lack of direct comparative efficacy data for cisplatin against other agents in the provided snippets."
      ],
      "missing_data": [
        "Specific details on the efficacy of cisplatin in different subtypes of esophageal cancer.",
        "Randomized controlled trials directly comparing cisplatin-based regimens against newer treatments for advanced esophageal cancer.",
        "Detailed pharmacogenomic data related to cisplatin response and resistance in esophageal cancer."
      ]
    },
    "9_recommended_next_steps": {
      "clinical_next_steps": [
        "Investigate combination therapies that enhance cisplatin efficacy in esophageal cancer.",
        "Explore strategies to overcome cisplatin resistance by targeting specific molecular pathways (e.g., miRNA regulation, FAM111B, autophagy).",
        "Consider clinical trials evaluating novel treatment regimens incorporating cisplatin with agents that modulate resistance mechanisms."
      ]
    },
    "10_claim_evidence_table": {
      "total_claims": 4,
      "claims": [
        {
          "claim_id": "CLM-2f9b27",
          "statement": "Cisplatin is a standard treatment for advanced esophageal cancer, and research is focused on overcoming cisplatin resistance.",
          "confidence_numeric": 0.9,
          "confidence_label": "HIGH",
          "polarity": "INCONCLUSIVE",
          "verification_status": "VERIFIED",
          "targets": [],
          "citation_count": 6,
          "risk_flags": []
        },
        {
          "claim_id": "CLM-e08970",
          "statement": "Dysregulation of specific miRNAs contributes to cisplatin resistance in esophageal cancer.",
          "confidence_numeric": 0.8,
          "confidence_label": "HIGH",
          "polarity": "INCONCLUSIVE",
          "verification_status": "PARTIALLY_VERIFIED",
          "targets": [],
          "citation_count": 4,
          "risk_flags": []
        },
        {
          "claim_id": "CLM-a01f13",
          "statement": "FAM111B promotes esophageal cancer tumorigenesis and cisplatin resistance.",
          "confidence_numeric": 0.14,
          "confidence_label": "LOW",
          "polarity": "INCONCLUSIVE",
          "verification_status": "UNVERIFIED",
          "targets": [],
          "citation_count": 1,
          "risk_flags": [
            "All evidence verification failed"
          ]
        },
        {
          "claim_id": "CLM-414f6f",
          "statement": "Cordycepin enhances chemosensitivity to cisplatin in esophageal cancer by activating AMPK and suppressing AKT signaling.",
          "confidence_numeric": 0.14,
          "confidence_label": "LOW",
          "polarity": "INCONCLUSIVE",
          "verification_status": "UNVERIFIED",
          "targets": [],
          "citation_count": 1,
          "risk_flags": [
            "All evidence verification failed"
          ]
        }
      ]
    },
    "11_provenance_appendix": {
      "total_entries": 4,
      "entries": [
        {
          "claim_id": "CLM-2f9b27",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "86629e6c1b2e",
          "timestamp": "2026-06-03T14:05:15.634665+00:00",
          "paper_evidence": [
            {
              "pmid": "38494800",
              "snippet": "Advanced esophageal carcinoma is one of the diseases with a poor prognosis. CF(cisplatin plus 5-FU)therapy and taxanes( paclitaxel or docetaxel)were considered standard treatments for first- and secon",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "36995552",
              "snippet": "Resistance to cisplatin, one of the majorly used chemotherapeutic drugs in EC, is a major nuisance.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37672204",
              "snippet": "Chemotherapeutic agents such as cisplatin are commonly used in patients with clinically unresectable or recurrent esophageal cancer (ESCA). However, patients often develop resistance to cisplatin, whi",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37401860",
              "snippet": "Cisplatin (CDDP) is a conventional chemotherapy drug. However, the acquired cisplatin resistance limits its extensively clinical applications.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "38251697",
              "snippet": "Providing insights into the chemoresistance of esophageal squamous cell carcinoma (ESCC) and its dependence on chemotherapy-induced autophagy.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "33067427",
              "snippet": "Although cisplatin (cDDP), is a first-line chemotherapy drug for esophageal cancer, it still has the potential to develop drug resistance and side effects.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 10
        },
        {
          "claim_id": "CLM-e08970",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "86629e6c1b2e",
          "timestamp": "2026-06-03T14:05:15.634665+00:00",
          "paper_evidence": [
            {
              "pmid": "36995552",
              "snippet": "This study sheds light on miRNA dysregulation and its inverse relation with dysregulated mRNAs to guide pathways into the manifestation of cisplatin resistance in EC.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "34277424",
              "snippet": "Our research aimed to reveal the function and mechanism of miR-135b-5p. Our research identified that miR-135b-5p was elevated in EC samples from TCGA database.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "37401860",
              "snippet": "LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            },
            {
              "pmid": "38251697",
              "snippet": "The objective of this study is to investigate the modulation of microRNA-30a (miR-30a), a known regulator of autophagy, in ESCC cells by all-trans retinoic acid (ATRA).",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 10
        },
        {
          "claim_id": "CLM-a01f13",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "86629e6c1b2e",
          "timestamp": "2026-06-03T14:05:15.634665+00:00",
          "paper_evidence": [
            {
              "pmid": "37672204",
              "snippet": "Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 10
        },
        {
          "claim_id": "CLM-414f6f",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "86629e6c1b2e",
          "timestamp": "2026-06-03T14:05:15.634665+00:00",
          "paper_evidence": [
            {
              "pmid": "33067427",
              "snippet": "Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.",
              "polarity": "SUPPORTS",
              "verification": "UNVERIFIED",
              "error": "Quote mismatch (fuzzy check failed)"
            }
          ],
          "mechanism_evidence": [],
          "queries_used_count": 10
        }
      ]
    }
  },
  "metadata": {
    "run_id": "86629e6c1b2e",
    "created_at": "2026-06-03T14:04:49.636808+00:00",
    "drug": "CISPLATIN",
    "disease": "esophageal cancer",
    "total_claims": 4,
    "quality_score": 0.709375,
    "reruns": 0
  }
}
```
